Edmond DE Rothschild Holding S.A. bought a new stake in shares of Xylem Inc. (NYSE:XYL – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 64,307 shares of the industrial products company’s stock, valued at approximately $7,602,000.
A number of other large investors also recently made changes to their positions in the stock. Commonwealth Retirement Investments LLC acquired a new stake in shares of Xylem during the fourth quarter worth $27,000. Wexford Capital LP acquired a new position in Xylem in the third quarter valued at about $27,000. Dunhill Financial LLC bought a new position in Xylem during the second quarter worth about $30,000. Avalon Trust Co bought a new position in Xylem during the second quarter worth about $35,000. Finally, Global Assets Advisory LLC bought a new stake in shares of Xylem in the 1st quarter valued at about $40,000. Institutional investors and hedge funds own 87.96% of the company’s stock.
Xylem Stock Performance
Shares of XYL stock opened at $116.28 on Thursday. Xylem Inc. has a 12 month low of $105.29 and a 12 month high of $154.27. The company’s fifty day simple moving average is $117.87 and its 200-day simple moving average is $120.03. The firm has a market cap of $27.15 billion, a PE ratio of 27.69, a P/E/G ratio of 1.58 and a beta of 1.02. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23.
Xylem Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th will be issued a $0.43 dividend. The ex-dividend date is Thursday, August 27th. This represents a $1.72 annualized dividend and a dividend yield of 1.5%. Xylem’s dividend payout ratio (DPR) is presently 40.95%.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on XYL shares. CLSA upgraded shares of Xylem to a “hold” rating in a research report on Thursday, June 25th. UBS Group boosted their price objective on shares of Xylem from $135.00 to $138.00 and gave the company a “neutral” rating in a report on Thursday, August 13th. Mizuho increased their target price on shares of Xylem from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Wednesday, July 29th. Oppenheimer reduced their price target on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 29th. Finally, Royal Bank Of Canada boosted their price target on shares of Xylem from $159.00 to $164.00 and gave the company an “outperform” rating in a report on Wednesday, July 29th. Nine analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, Xylem presently has an average rating of “Moderate Buy” and an average price target of $154.23.
Read Our Latest Stock Report on XYL
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
- Five stocks we like better than Xylem
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
